Telix Pharmaceuticals Limited Cash Flows From Used In Investing Activities
Telix Pharmaceuticals Limited (TLPPF) reported Cash Flows From Used In Investing Activities of -$285.92 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-20.
Financial Statements › Cash Flow › Investing Activities
ifrs-full:CashFlowsFromUsedInInvestingActivities · last filed 2026-02-20
AUD
| Period end | Cash Flows From Used In Investing Activities 12 month |
|---|---|
| 2024-12-31 | -135.17M AUD 20-F · filed 2025-02-24 |
| 2023-12-31 | -25.49M AUD 20-F · filed 2025-02-24 |
| 2022-12-31 | -17.00M AUD 20-F · filed 2025-02-24 |
USD
| Period end | Cash Flows From Used In Investing Activities 12 month |
|---|---|
| 2025-12-31 | -$285.92M 20-F · filed 2026-02-20 |
| 2024-12-31 | -$86.69M 20-F · filed 2026-02-20 |
| 2023-12-31 | -$16.84M 20-F · filed 2026-02-20 |